Onderneming M Pharmaceutical Inc Deutsche Boerse AG
Aandelen
CA55346E2050
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Consumer Health and Wellness Products
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -5,46% |
Verkoop per regio
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -5,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 03-01-18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Joshua Maurice
SAM | Sales & Marketing | - | 01-09-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01-12-14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 271 962 | 32 615 816 ( 72,04 %) | 0 | 72,04 % |
Bedrijfsgegevens
Callitas Health, Inc.
187 Pavilion Parkway Suite 200
41071, Newport
+859 868 3131
http://www.callitas.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+48,77% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |